Program Plenary Speakers
Introducing the 2017 Plenary Speakers. Click on the speaker names below to quickly view biography information:

Paul Anastas, PhD
Yale University

Paul T. Anastas is the Teresa and H. John Heinz III Professor in the Practice of Chemistry for the Environment. He has appointments  in the School of Forestry and Environmental Studies, Department of Chemistry, and Department of Chemical Engineering. In addition, Prof. Anastas serves as the Director of the Center for Green Chemistry and Green Engineering at Yale. Anastas took public service leave from Yale to serve as the Assistant Administrator for the US Environmental Protection Agency and the Agency Science Advisor from 2009-2012. From 2004 -2006, Paul Anastas served as Director of the ACS Green Chemistry Institute in Washington, D.C. He was previously the Assistant Director for the Environment in the White House Office of Science and Technology Policy where he worked from 1999-2004. Trained as a synthetic organic chemist, Dr. Anastas received his Ph.D. from Brandeis University and worked as an industrial consultant. He is credited with establishing the field of green chemistry during his time working for the U.S. Environmental Protection Agency as the Chief of the Industrial Chemistry Branch and as the Director of the U.S. Green Chemistry Program. Dr. Anastas has published widely on topics of science through sustainability including eleven books, such as Benign by Design, Designing Safer Polymers, Green Engineering, and his seminal work with co-author John Warner, Green Chemistry: Theory and Practice.

Hiroaki Kitano, PhD
Professor, Okinawa Institute of Science and Technology Graduate University
President, The Systems Biology Institute
President & CEO, Sony Computer Science Laboratories, Inc.

Hiroaki Kitano is a President & CEO at Sony Computer Science Laboratories, Inc., Corporate Executive at Sony Corporation, a President at The Systems Biology Institute, Tokyo, a Professor at Okinawa Institute of Science and Technology Graduate University, Okinawa, and a Group Director of Laboratory for Disease Systems Modeling at RIKEN Center for Integrative Medical Sciences, Kanagawa.

He received a B.A. in physics from the International Christian University, Tokyo, and a Ph.D. in computer science from Kyoto University.  Since 1988, he has been a visiting researcher at the Center for Machine Translation at Carnegie Mellon University.  His research career includes a Project Director at Kitano Symbiotic Systems Project, ERATO, Japan Science and Technology Corporation followed by a Project Director at Kitano Symbiotic Systems Project, ERATO-SORST, Japan Science and Technology Agency.

Kitano is also a Manager of Division of Cancer Systems Biology, Cancer Institute, Japanese Foundation for Cancer Research, an Editor-in-Chief of npj Systems Biology and Applications, a Founding President of The RoboCup Federation, and an active member of World Economic Forum’s Global Future Council on Enablers of the Fourth Industrial.
Kitano received The Computers and Thought Award from the International Joint Conferences on Artificial Intelligence in 1993, Prix Ars Electronica 2000, Japan Design Culture Award 2001, Good Design Award 2001, and Nature’s 2009 Japan Mid-career Award for Creative Mentoring in Science, as well as being an invited artist for Biennale di Venezia 2000 and Museum of Modern Art (MoMA) New York at Worksphere Exhibition in 2001.

Daniel Krewski, PhD
University of Ottawa

Daniel Krewski is the Associate Scientific Director, PrioNet Canada / Director, R. Samuel McLaughlin Centre for Population Health Risk Assessment, University of Ottawa. Dr. Daniel Krewski was appointed Associate Scientific Director of PrioNet Canada in January 2008. He is the Director of the McLaughlin Centre for Population Health Risk Assessment where he holds the position of NSERC Industrial Research Chair in Risk Science. Dr. Krewski has been Professor in the Department of Epidemiology and Community Medicine in the Faculty of Medicine at the University of Ottawa since 1998. His professional interests are in epidemiology, biostatistics, risk assessment, and risk management and he has broad experience applied to national and international panels of experts in the fields of health, life sciences, chemical safety, cancer and environmental hazards. Dr. Krewski is a Fellow of the American Statistical Association and the Society for Risk Analysis, and a lifetime National Affiliate of the U.S. National Academy of Sciences. He is also the Scientific Director of the PAHO/WHO Collaborating Centre in Population Health Risk Assessment at the University of Ottawa. Dr. Krewski has contributed to over 450 publications in the scientific and technical literature, and is author or editor of six books.

Margaret S. Landi, VMD, MS
Diplomate ACLAM

Margaret is the Chief of Animal Welfare, Ethics and Strategy for GlaxoSmithKline.  Margaret is a Diplomate in the American College of Laboratory Animal Medicine (ACLAM) and Past- President of the organization.  She has served on the Council of the Institute of Laboratory Animal Research (ILAR), a part of the National Academy of Science and is presently Chair of ILAR Council and is a member of the roundtable on laboratory animal medicine and science.  She served on review committees of the National Institutes of Health (NIH) and has led special site visit teams for NIH Committees.  A graduate of William Paterson with a bachelor’s degree in biology, Margaret earned her veterinary degree (VMD) from the University of Pennsylvania’s School of Veterinary Medicine and a MS degree in Comparative Medicine from The Hershey Medical of Penn State University.  In Dec 2016 she received her Master’s in Bioethics from the University of Pennsylvania.  Margaret serves currently on the Board of Trustees for the Scientists Center for Animal Welfare and the Board of Directors for Americans for Medical Progress and Chimp Haven, and she is Chair of the ILAR Council.

Margaret has received Distinguish Alumni Awards from William Paterson and the University of Pennsylvania and has been awarded both the Charles River Prize and the Pennsylvania Veterinary Medical Association’s Veterinarian of the Year Award. She is also a recipient of the Harry Rowsell Award from the Scientists Center for Animal Welfare.

Margaret served on the Institute of Medicine Committee on the Future of Chimpanzees in Biomedical and Behavioral Research.  The Committee published its report in Dec 2011; Chimpanzees in Biomedical and Behavioral Research:  Assessing the Necessity. She has published and presented papers on a number of topics related to laboratory animal medicine, welfare and science.  Her areas of concentration include in the application of global principles for laboratory animals in an international arena with differing laws, cultures, regulations and policies and her recent interest is in the applicability of moral considerability during IACUC deliberations (Landi, Shriver and Mueller "Consideration and checkboxes: incorporating ethics and science into the 3Rs." Journal of the American Association for Laboratory Animal Science 54.2 (2015): 224-230.)

Jacques Leclaire, PhD
Scientific Director of the L’Oréal Group, Research & Innovation

Following a post-doctoral thesis and a PhD in Physical Sciences and Organic Chemistry, Jacques Leclaire started his professional career at the French National Centre for Scientific Research (CNRS), in the Chemistry laboratory of the Ecole Normale Supérieure led by Prof. Marc Julia, as a research assistant for two years, under the supervision of Prof. Dominique Mansuy.

Jacques Leclaire then joined Roussel-Uclaf in the pharmaceuticals industry, where in 1988 he created the Molecular Toxicology unit with the aim of predicting potential side effects and drug interactions of candidate molecules. This predictive evaluation capability was truly a precursor of developments to come. In 1991, Jacques was appointed Head of the Toxicology Department, in charge of international drug development and the elaboration of market authorization dossiers.

In 1993, Jacques joined L’Oréal as Director of the Corporate Product Safety Department to develop a strategy to implement alternative methods to animal testing in the field of safety. In 1994, he was appointed Director of Life Sciences, a department that conducts research in the fields of toxicology and biology. In 2011, his Department employed 300 scientists working on basic and applied research programs in the field of Life Sciences, devoted to cosmetics and dermatology. As a firm believer in collaborative partnerships between academia and industry, Jacques has fostered long-standing ties with scientists around the world, many of whom continue to have long-term relationships with L’Oréal research.

He also developed L’Oréal’s more recent biology disciplines such as “Omics” from the end of the 1990s, and actively supported research into reconstructed human skin and other predictive methods of evaluating safety, efficacy and environmental impact, which are at the core of the L’Oréal’s commitment to sustainable development.

From 1997 to 2011, Jacques Leclaire jointly managed the scientific and technological aspects of the company Episkin (a subsidiary of L'Oréal, specialized in tissue engineering for the industrial production of reconstructed human skin for research and evaluation).

Since 2002, Jacques has been a member of the International Jury for the L'Oréal-UNESCO Women In Science Award.
He has been a member of the Academy of Technologies since 2003.
In March 2011, Jacques Leclaire was appointed Scientific Director of the L’Oréal Group. In this role he manages L'Oréal’s international Scientific Advisory Board which he created. Comprised of 10 eminent scientists working in a variety of disciplines, the aim of this Board is to propose innovative ideas for the Group’s avenues of research to prepare the future by exploring emerging fields.

In 2012, Jacques Leclaire was appointed Chevalier of the French Légion d’Honneur.

In 2013, he was appointed administrator of the French Academy of Medicine.

Peggy Mason, PhD
University of Chicago

Peggy Mason grew up in the Washington DC area and worked in taxidermy at the Smithsonian Museum of Natural History under the direction of the late Dr Charles O Handley Jr. She went to college at Harvard, graduating with a degree in Biology in 1983. She received her PhD in Neuroscience from Harvard in 1987. After postdoctoral work at the University of California - San Francisco under the direction of Dr Howard Fields, she joined the faculty at the University of Chicago in 1992. Dr Mason is now Professor of Neurobiology. Dr Mason is committed to teaching neurobiology to anyone that will listen. She has taught medical students since her arrival at UChicago, with the exception of a 2 year hiatus during which she wrote a textbook, Medical Neurobiology, the second edition of which just came out (Oxford University Press, 2017). Dr Mason is the Director of the Neuroscience major at the University of Chicago and teaches undergraduates both on the Chicago campus and in Paris! She is a sought after mentor. She also offers a massively open on-line course, Understanding the Brain: The Neurobiology of Everyday Life to the public; this course has served 100,000 students and counting. Visit the blog, The brain is sooooo cool! for Dr Mason’s musings on the neurobiology that is all around us.

For more than 20 years, Dr Mason's research was focused on the cellular mechanisms of pain modulation. In the last 8 years, she has turned her attention to the biology of empathy and helping behavior. This work has garnered widespread attention and stimulated many new conversations.

Jonathan M. Samet, MD, MS
Distinguished Professor, Flora L. Thornton Chair, Department of Preventive Medicine, University of Southern California Keck School of Medicine
Director, University of Southern California Institute for Global Health
University of Southern California

Jonathan M. Samet, a pulmonary physician and epidemiologist, is currently Distinguished Professor and Flora L. Thornton Chair for the Department of Preventive Medicine at the Keck School of Medicine at the University of Southern California and Director, USC Institute for Global Health. Previously, he was chair of the Department of Epidemiology of the Johns Hopkins Bloomberg School of Public Health. Dr. Samet received a Bachelor’s degree in Chemistry and Physics from Harvard College, an M.D. degree from the University of Rochester, School of Medicine and Dentistry, and a Master of Science degree in Epidemiology from the Harvard School of Public Health. His research has focused on the health risks of inhaled pollutants—particles and ozone in outdoor air and indoor pollutants including secondhand smoke and radon. He has also investigated the occurrence and causes of cancer and respiratory diseases, emphasizing the risks of active and passive smoking. For several decades, he has been involved in global health, focusing on tobacco control, air pollution, and chronic disease prevention. He has served on and chaired numerous committees of the National Research Council and Institute of Medicine, and as chair of the Clean Air Scientific Advisory Committee of the U.S. EPA and the FDA’s Tobacco Products Scientific Advisory Committee. For the National Research Council, he chaired, among others, the Biological Effects of Ionizing Radiation (BEIR) VI Committee; the Committee on Research Priorities for Airborne Particulate Matter, Board on Environmental Studies and Toxicology; the Committee to Review the Draft IRIS Assessment on Formaldehyde; the Committee to Develop a Research Strategy for Environmental Health and Safety Aspects of Engineered Nanomaterials; the Committee to Review the IRIS Process; and the Committee on Incorporating 21st Century Science into Risk-Based Evaluations. Dr. Samet has served as Editor and Author for Reports of the Surgeon General on Smoking and Health since 1984, receiving the Surgeon General’s Medallion in 1990 and 2006 for these contributions. He was the Senior Scientific Editor for the 50th Anniversary 2014 report. Dr. Samet received the 2004 Prince Mahidol Award for Global Health awarded by the King of Thailand, the Alton Ochsner Award Relating Smoking and Health, the WHO World No Tobacco Day Award, the Edward Livingston Trudeau Medal from the American Thoracic Society/American Lung Association, the Luther L. Terry Award for Distinguished Career from the American Cancer Society and the Fries Prize for Improving Health from the CDC Foundation in 2016. He received the Alumni Award of Merit from the Harvard School of Public Health, and was named Distinguished Alumnus of the Year by the University of Rochester School of Medicine and Dentistry. He was elected to the National Academy of Medicine (Institute of Medicine) of the National Academy of Sciences in 1997 and received the David M. Rall Medal for his contributions in 2015. He received a Doctorate Honoris Causae from the Instituto Nacional de Salud Publica (INSP) Mexico in 2017.

Peter Sandøe
University of Copenhagen

Peter Sandøe has been professor of bioethics at the University of Copenhagen since 1997. The major part of his research has focused on ethical issues related to animals, biotechnology and food production. He is committed to interdisciplinary work combining perspectives from natural science, social sciences and philosophy and publishes in a wide range of scholarly journals. His books include Ethics of Animal Use (co-authored with Stine B. Christiansen), published by Blackwell 2008, and Companion Animal Ethics (co-authored with Sandra Corr and Clare Palmer), published by Wiley/Blackwell 2016.

Russell S. Thomas, PhD
National Center for Computational Toxicology, U.S. Environmental Protection Agency

Russell Thomas is the director of the National Center for Computational Toxicology at the U.S. Environmental Protection Agency.  The Center is researching new, more efficient, ways to evaluate the safety of chemicals, particularly in assessing chemicals for human health effects.  Dr. Thomas has a broad, multidisciplinary background and experience.  Dr. Thomas’ formal academic training includes a B.A. in chemistry from Tabor College, an M.S. in radiation ecology and health physics from Colorado State University, and a Ph.D. in toxicology also at Colorado State.  Following his doctoral studies, Dr. Thomas performed postdoctoral research in molecular biology and genomics at the McArdle Cancer Research Laboratory at the University of Wisconsin.  Following his academic training, Dr. Thomas performed bioinformatics and genomics research in the biotechnology sector and gained experience in high-throughput screening and in vitro assay development in the biopharma sector. Prior to coming to the U.S. EPA, Dr. Thomas worked as an investigator and the director of the Institute for Chemical Safety Sciences at The Hamner Institutes for Health Sciences.